CRO Analytics Named “Company to Watch” by PACT 22nd Annual Enterprise Awards
New Hope, PA, February 13, 2015 --(PR.com)-- CRO Analytics, the leading provider of validated clinical trial performance data, was recognized as a “Company to Watch” by the Greater Philadelphia Alliance for Capital and Technologies (PACT) 2015 Enterprise Awards.
The Enterprise Awards remain the region's most prestigious business honors for technology and life sciences companies, leaders, and entrepreneurs. Presented by PACT, in sponsorship with KPMG, the awards attract more than 900 prominent business leaders and celebrate achievement, innovation, and success in the Greater Philadelphia region.
“We are honored to be recognized among such an elite group of business leaders, innovators and entrepreneurs by this prestigious organization,” said Peter Malamis, CEO of CRO Analytics. “Our mission is to improve clinical trial performance by providing the insights that make trials less costly and faster thereby getting new and improved treatments to patients sooner.”
CRO Analytics recently launched the Pilot to Production program of its Clinical Trial Quality System, Performer™, a cloud-based software platform designed to improve clinical research by assessing clinical trial performance. The company also announced investments from LabWare, Ben Franklin Technology Partners of Southeastern Pennsylvania, and the newly established Venture Capital for Bucks County Fund in December.
On March 20, 2015 CRO Analytics is hosting a half-day seminar on “Assessing and Improving Clinical Trial Quality,” to provide insight and guidance on how clinical trial quality can be improved through scientific quality measurement. The seminar will be led by Dr. Michael Howley, Clinical Professor, LeBow School of Business at Drexel University, and Nancy Santanello, MD, MS, former Merck VP of Epidemiology will present on "Including Patient-Centricity in Clinical Research." Additional details and tickets are available on the CRO Analytics’ website or at http://bit.ly/CROAnalyticsSeminar.
About CRO Analytics
CRO Analytics provides the only validated performance data collection system for clinical trials, providing straightforward access to reliable benchmarking, key performance drivers and predictive analytics in an intuitive format - making clinical research better, faster and less expensive. To learn more, please visit croanalytics.com.
About Performer™
Performer™, the biopharma industry’s first Clinical Trial Quality System, is a cloud-based software platform designed to improve clinical research by assessing clinical trial performance through a series of instruments developed over a two-year validation process. The online tools, which take less than five minutes to complete, measure the quality of more than 70 functional areas and professional skills involved in clinical trial delivery. The data is analyzed using a series of algorithms to deliver actionable insights through standard and custom reports to clinical trial teams, functional area leads, and executives.
About the Performer™ Pilot to Production Program
The Pilot to Production program provides a limited number of sponsors and CRO partners with the opportunity to work over a six-month period with CRO Analytics to develop a deeper understanding of how Performer is used, adds value, and can be improved prior to its full launch next year.
Those interested in participating in Pilot to Production are asked to contact CRO Analytics CEO, Peter Malamis at pmalamis@croanalytics.com.
The Enterprise Awards remain the region's most prestigious business honors for technology and life sciences companies, leaders, and entrepreneurs. Presented by PACT, in sponsorship with KPMG, the awards attract more than 900 prominent business leaders and celebrate achievement, innovation, and success in the Greater Philadelphia region.
“We are honored to be recognized among such an elite group of business leaders, innovators and entrepreneurs by this prestigious organization,” said Peter Malamis, CEO of CRO Analytics. “Our mission is to improve clinical trial performance by providing the insights that make trials less costly and faster thereby getting new and improved treatments to patients sooner.”
CRO Analytics recently launched the Pilot to Production program of its Clinical Trial Quality System, Performer™, a cloud-based software platform designed to improve clinical research by assessing clinical trial performance. The company also announced investments from LabWare, Ben Franklin Technology Partners of Southeastern Pennsylvania, and the newly established Venture Capital for Bucks County Fund in December.
On March 20, 2015 CRO Analytics is hosting a half-day seminar on “Assessing and Improving Clinical Trial Quality,” to provide insight and guidance on how clinical trial quality can be improved through scientific quality measurement. The seminar will be led by Dr. Michael Howley, Clinical Professor, LeBow School of Business at Drexel University, and Nancy Santanello, MD, MS, former Merck VP of Epidemiology will present on "Including Patient-Centricity in Clinical Research." Additional details and tickets are available on the CRO Analytics’ website or at http://bit.ly/CROAnalyticsSeminar.
About CRO Analytics
CRO Analytics provides the only validated performance data collection system for clinical trials, providing straightforward access to reliable benchmarking, key performance drivers and predictive analytics in an intuitive format - making clinical research better, faster and less expensive. To learn more, please visit croanalytics.com.
About Performer™
Performer™, the biopharma industry’s first Clinical Trial Quality System, is a cloud-based software platform designed to improve clinical research by assessing clinical trial performance through a series of instruments developed over a two-year validation process. The online tools, which take less than five minutes to complete, measure the quality of more than 70 functional areas and professional skills involved in clinical trial delivery. The data is analyzed using a series of algorithms to deliver actionable insights through standard and custom reports to clinical trial teams, functional area leads, and executives.
About the Performer™ Pilot to Production Program
The Pilot to Production program provides a limited number of sponsors and CRO partners with the opportunity to work over a six-month period with CRO Analytics to develop a deeper understanding of how Performer is used, adds value, and can be improved prior to its full launch next year.
Those interested in participating in Pilot to Production are asked to contact CRO Analytics CEO, Peter Malamis at pmalamis@croanalytics.com.
Contact
CRO Analytics
Margretta Feuer
215-230-9024
http://croanalytics.com
Margretta Feuer
215-230-9024
http://croanalytics.com
Contact
Categories